4:05 PM ET
Form 4
Insider Selling
Travere Therapeutics CEO Eric M. Dube Sells $13.1M of Stock
Eric M. Dube, CEO, sold 243,735 shares of Travere Therapeutics, Inc. at $52.97 to $55.02 a share (average $53.82) in 3 transactions, worth $13.1M in total on Oct 15, 2026. Shares held after the trade: 432,886 (-15.3%).
- Value
- $13.1M
- Shares
- 243,735
- Average price
- $53.82
- Role
- CEO
- Holding change
- -15.3%
- Trade date
- Oct 15, 2026